Shareholders, get ready for the Annual General Meeting on May 24!

Dernièrement…

📅 [#WEBINAIRE] Ne ratez pas notre webinaire dédié à la transition engagée d'@AmoebaNature le 31 mai à 15h. Inscription gratuite 👉https://www.boursedirect.fr/fr/formations/webinaire/amoeba-transition-engagee https://twitter.com/AmoebaNature/status/1527192716286763008

📢 L’équipe s’agrandit chez Amoéba!
Hervé Testeil prend la Direction Industrielle d’#Amoéba avec un objectif précis: structurer la #stratégie d’innovation et transformer nos découvertes en procédés industrialisables pour des produits de qualité. Retrouvez son portrait ci-dessous. 2

📹 #Amoéba a le plaisir d’annoncer l’organisation de son premier #webinaire avec @boursedirect le 31 mai prochain.
@FabricePlasson reviendra sur les dernières annonces réglementaires et présentera les projets de #développement à venir. Pour s'inscrire👉 https://bit.ly/3Luolsx

🗳 J-7 : Prochaine #AssembléeGénérale, le 24/05/2022

Actionnaires $ALMIB, on compte sur vous ! Plus qu’une semaine pour envoyer votre #formulaire de vote ou voter via #Votaccess ! Retrouvez toutes les informations, documents et #procédures sur https://amoeba-nature.com.

An amoeba to help the eco-industry

Willaertia magna C2c Maky

Amoéba develops applications by exploiting the characteristics of the amoeba Willaertia magna C2c Maky. This amoeba has been isolated from the environment and has natural properties.

Discover
Investor

Lastest news


6 May 2022

Ordinary and extraordinary general meeting to be held on 24 May 2022

Amoéba announces the availability of preparatory documents for the General Assembly of May 24, 2022


3 May 2022

Amoeba: Malta recommends the non-approval of the “biocide” active substance for the European territory

Amoeba announces that the Maltese authority recommends the non-approval of the biocidal active substance for the European territory


25 April 2022

Amoéba: Austria recommends the approval of the biocontrol application in Europe

Amoéba announces that AGES, in charge of the application for approval of the biocontrol active substance “Lysate of Willaertia magna C2c Maky”, recommends its approval for use in plant protection on the European territory.


13 April 2022

Amoéba : Publication of the 2021 Universal Registration Document

Amoéba announces that the 2021 Universal Registration Document was filed with the French Financial Markets Authority (Autorité des marchés financiers AMF) on April 12, 2022.

Discover the news

📅 [#WEBINAIRE] Ne ratez pas notre webinaire dédié à la transition engagée d'@AmoebaNature le 31 mai à 15h. Inscription gratuite 👉https://www.boursedirect.fr/fr/formations/webinaire/amoeba-transition-engagee https://twitter.com/AmoebaNature/status/1527192716286763008

📢 L’équipe s’agrandit chez Amoéba!
Hervé Testeil prend la Direction Industrielle d’#Amoéba avec un objectif précis: structurer la #stratégie d’innovation et transformer nos découvertes en procédés industrialisables pour des produits de qualité. Retrouvez son portrait ci-dessous. 2

📹 #Amoéba a le plaisir d’annoncer l’organisation de son premier #webinaire avec @boursedirect le 31 mai prochain.
@FabricePlasson reviendra sur les dernières annonces réglementaires et présentera les projets de #développement à venir. Pour s'inscrire👉 https://bit.ly/3Luolsx

🗳 J-7 : Prochaine #AssembléeGénérale, le 24/05/2022

Actionnaires $ALMIB, on compte sur vous ! Plus qu’une semaine pour envoyer votre #formulaire de vote ou voter via #Votaccess ! Retrouvez toutes les informations, documents et #procédures sur https://amoeba-nature.com.

Business

Amoéba is a Lyonnaise cleantech, an innovative player in the treatment of bacterial risk.

At the crossroads of environmental protection and public health issues, we are developing a three-fold scientific, industrial and commercial expertise. The company is developing around multiple applications using the amoeba Willaertia magna C2c Maky in the prevention of microbiological risk for water treatment, human wounds and plant protection.

Discover

Biocide

The only biological biocide that can be used in air cooling towers, with no hazard class for human health and the environment.

Water treatment

Our disruptive biocide helps control the level of Legionella, both those present in the water and those colonizing the biofilm.

The effectiveness of the biocide is due to the natural properties of the amoeba Willaertia magna C2c Maky, which predates pathogenic bacteria and other free-standing amoebae.

For the first time in 50 years of industrial water treatment, Amoéba is giving industry the opportunity to choose a responsible alternative.

Learn more

Testimonials

The industry professionals testify about their experiences with the biological biocide BIOMEBA.

Dalkia

Jean-Michel CLAUDE

Vitacuire

Yves GAGNE

Häagen Dazs

Olivier BERTRAND
All our testimonials

Biocontrol

Plants protection

We found that mechanically lysed amoeba Willaertia magna C2c Maky exhibited strong fungicidal properties.

First on oomycetes (microorganisms close to fungi and responsible for mildews) then on phytopathogenic fungi such as rusts, powdery mildew, etc.

This has been demonstrated in laboratory tests and then, since 2019, has been verified in field trials.

Learn more

Research & Development

Other research is currently being conducted in order to make the best use of Willaertia magna C2c Maky’s different properties.

These properties open up a wide range of applications, particularly at the interface between health and environment fields.

All about it
‘’ A UNIQUE MICRO-ORGANISM ‘’